Evidence map›Paper›PMID 32804350›Full record

ArticleReproductive sciences (Thousand Oaks, Calif.)2021

Serum Decorin, Biglycan, and Extracellular Matrix Component Expression in Preterm Birth.

Jenna M Mennella, Lori A Underhill, Sophia Collis, Geralyn M Lambert-Messerlian, Richard Tucker, Beatrice E Lechner

Open access · hybridAbstract read
In one paragraph

Article in Reproductive sciences (Thousand Oaks, Calif.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Development of a spontaneous preterm birth predictive model using a panel of serum protein biomarkers for early pregnant women: A nested case-control study.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2025
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jenna M MennellaWarren Alpert Medical School at Brown University, Providence, RI, USA. jmennella@wihri.org.ORCID 0000-0002-8107-3767
Lori A UnderhillWarren Alpert Medical School at Brown University, Providence, RI, USA.
Sophia CollisBrown University, Providence, RI, USA.
Geralyn M Lambert-MesserlianWarren Alpert Medical School at Brown University, Providence, RI, USA.
Richard TuckerDepartment of Pediatrics, Women and Infants Hospital, Providence, RI, USA.
Beatrice E LechnerWarren Alpert Medical School at Brown University, Providence, RI, USA. blechner@wihri.org.ORCID 0000-0002-3730-9082
Brown University · USProvidence College · US

Funding

Transcriptional Profiling of Exosomes Defines Molecular Phenotype of PreclampsiaP20GM121298 · NIGMS · WOMEN AND INFANTS HOSPITAL-RHODE ISLAND · PI SHARMA, SURENDRA · 2017 to 2021
$12.6M
NIGMS NIH HHS P20 GM121298
6 · The paper itself

Abstract

Preterm birth is a leading cause of infant morbidity and mortality. Decorin and biglycan are proteoglycans that play key roles in maintaining the connective tissue matrix and tensile strength of human fetal membranes and have been previously linked to PPROM. Extracellular matrix proteins, such as matrix metalloproteinase 2 (MMP-2), matrix metalloproteinase 9 (MMP-9), TIMP metallopeptidase inhibitor 1 (TIMP-1), TIMP metallopeptidase inhibitor 2 (TIMP-2), and collagen VI (COL-6), have also been linked to PPROM and may have utility in a serum-based screening model for this condition. To define the natural course of serum decorin and biglycan expression throughout the duration of healthy pregnancy, to explore patterns of serum decorin and biglycan expression in serum of asymptomatic women who go on to develop spontaneous preterm labor, and to investigate the potential role for matrix metalloproteinases, their inhibitors, and collagen VI in a serum-based screening model to predict PPROM. Serum decorin level decreases less than 1% per week, and serum biglycan decreases by 2.9% per week over the duration of healthy pregnancy. Serum decorin and biglycan concentrations do not differ in spontaneous preterm labor cases compared with those in controls. Mean concentrations of MMP-2, MMP-9, TIMP-1, TIMP-2, and COL-6 do not differ in PPROM cases compared with those in controls. We have demonstrated that serum decorin and biglycan concentrations remain stable throughout the duration of normal pregnancy and are not early indicators of preterm labor, while common MMPs, TIMPs, and collagen VI are not early indicators of PPROM.

Indexed as

BiglycanBiomarkersCollagen Type VIDecorinEnzyme-Linked Immunosorbent AssayExtracellular Matrix ProteinsFemaleHumansMatrix MetalloproteinasesPredictive Value of TestsPregnancyPremature BirthPremature Rupture of Fetal MembranesRetrospective StudiesTissue Inhibitor of MetalloproteinasesBGN protein, humanBiglycanBiomarkersCollagen Type VIDCN protein, humanDecorinExtracellular Matrix ProteinsMatrix MetalloproteinasesTissue Inhibitor of MetalloproteinasesBiglycanBiomarkersDecorinPPROMPreterm birth

Identifiers

PMID32804350
PMCPMC7782456
OpenAlexW3075584339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.